Results: Disease treated by ICS were chronic rhinosinusitis in 39.2% for a mean duration of 30 days in 62.2% of the cases, aergic rhinitis in 69.2 %, nasal polyposis in 67.2%, and OME in 30.2%. Acute rhinosinusitis was considered for treatment by intranasal corticosteroids by only 8.5% of otolaryngologists. Adenoid hypertrophy was treated in 16% of cases by ICS. Symptoms considered for treatment by ICS were nasal obstruction (88.6%), rhinorrhea (67.6%), nasal itching (66.1%), ocular symptoms (41.2%), sneezing (63%), olfactory troubles (73.2%), dyspnea (76%), edema of nasal mucosa (76.2%). Fever was never an indication (75%).
Objective: The discovery of propanolol for treatment of hemangiomas is a breakthrough, as current modalities are hampered by unpredictable outcomes and complications. Currently, there is a lack of long-term data. We aim to contribute with our series of 3 patients with subglottic hemangiomas causing airway compromise, treated successfully with propanolol.
Method:
A detailed retrospective review of 3 patients who had received oral propanolol for the treatment of their subglottic hemangiomas was conducted based on the patients' records. We documented their clinical history, degree of airway compromise, and duration of treatment and outcome with oral propanolol.
Results: Patient 1 was a 23-day-old girl who had a 1-week history of stridor complicated by spontaneous rib fractures. Patient 2 was a 3-month-old girl who had a 1-month history of stridor associated with a beard distribution of cutaneous hemangiomas. Patient 3 was a 2-month-old girl who had intermittent stridor from third week of birth. All children required intubation for relief of respiratory distress. Microlaryngobronchoscopy was performed for diagnosis and follow-up at regular intervals. Cardiac echography was done prior to oral propanolol commencement at 1mg/kg/d, which was gradually escalated to 2mg/kg/d. All patients demonstrated significant clinical improvement at one week.
Conclusion: While the patients demonstrated remarkable clinical improvement at one week, radiological response (magnetic resonance imaging) was muted in contrast. This remarkable clinical response was not found to be sustained at 6 months interval. Propanolol may have to be combined with another modality of treatment to achieve a long-term positive outcome.
Pediatric Otolaryngology Treatment of Lymphatic Malformations: A Systematic Review
Mary Theresa Adams, MD (presenter); Babette S. Saltzman; Jonathan A. Perkins, DO Objective: 1) Systematically review the literature pertaining to head and neck (H&N) lymphatic malformation (LM) treatment, and use individual level data presented in qualifying case-series to compare efficacy, complications, and functional impact among surgery and sclerotherapy. 2) Evaluate whether treatment modalities differed by LM stage.
Method: Using Ovid and search terms lymphangioma, cystic hygroma, and lymphatic malformation, we performed a literature search yielding 6,292 references. Excluding references that did not: involve H&N LM treatment, include at least 5 patients, follow patients for one year, define treatment, and state complications, yielded 29 articles with individual level data.
Results: We pooled individual case data from case series, indentifying 157 patients treated with surgery and 132 patients treated with sclerotherapy. Advanced stage LM were more likely to be treated with surgery (24 (15.8%)) than sclerotherapy (34 (28.1%)). Advanced stage LM had increased levels of persistence in both surgically treated and sclerosed patients. One sclerotherapy treatment was used in 45 (34%), 2 in 35 (26.5%), and three or more in the remainder. The report of complications and functional impact was inconsistent among papers.
Conclusion: Currently no standardized reporting system of LM case series exists, making it difficult to compare treatments. Our data suggest that sclerotherapy may be more efficacious, with fewer side effects than surgery; however, our evaluation did not take into account the potentially confounding effects of LM stage, treatment indications, and complications.
Pediatric Otolaryngology
Ultrasound Imaging to Identify Occult Submucous Cleft Palate Jeremy D. Meier, MD (presenter); Caroline A. Banks, MD; David R. White, MD Objective: 1) Determine the feasibility of transoral ultrasound imaging in evaluating palatal anatomy using a human cadaver model. 2) Describe ultrasound findings in patients with a submucous cleft palate.
Method: Ultrasound imaging of the soft palate in twenty fresh human cadaver specimens was performed using the Sono Site
